Rabies Vaccine(Human diploid cell)(Dalian Aleph Biomedical)

冻干人用狂犬病疫苗（人二倍体细胞）（复星雅立峰（大连）生物）

Report date: 2026/04/28 20:00:22

Base Information

Drug NameRabies Vaccine(Human diploid cell)(Dalian Aleph Biomedical)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRabies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesDalian Aleph Biomedical Company Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDalian Aleph Biomedical Company Ltd
Inactive CompaniesN/A
Active IndicationsRabies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A